Tag: alpha spending

Communicating Interim Results to Sponsors, Regulators and Investigators In the context of clinical trials, the communication of interim results is a critical aspect that can significantly influence decision-making processes for sponsors, regulators, and investigators. Interim analyses allow stakeholders to assess the progress and efficacy of the trial, which can lead to essential adjustments based on…

Read More “Communicating Interim Results to Sponsors, Regulators and Investigators” »

Operationalizing Interim Analyses Across Global Trial Infrastructures Operationalizing Interim Analyses Across Global Trial Infrastructures In the landscape of clinical research, interim analyses are pivotal in maintaining the integrity and efficiency of clinical trials. This step-by-step tutorial guide aims to illuminate the operationalization of interim analyses across various global trial infrastructures. Designed for clinical operations, regulatory…

Read More “Operationalizing Interim Analyses Across Global Trial Infrastructures” »

Simulating Interim Strategies to Optimize Power and Type I Error Simulating Interim Strategies to Optimize Power and Type I Error In the highly regulated environments of clinical trials, ensuring that methodologies for statistical analysis are both rigorous and compliant with FDA, EMA, and ICH-GCP guidelines is paramount. This article provides a comprehensive step-by-step tutorial guide…

Read More “Simulating Interim Strategies to Optimize Power and Type I Error” »

Interim Analyses in Rare Disease, Oncology and High-Risk Studies Interim Analyses in Rare Disease, Oncology and High-Risk Studies Interim analyses play a crucial role in the management and success of clinical trials, especially in fields such as rare diseases, oncology, and high-risk studies. This tutorial provides a comprehensive step-by-step guide for clinical operations, regulatory affairs,…

Read More “Interim Analyses in Rare Disease, Oncology and High-Risk Studies” »

Case Studies: Interim Analyses That Stopped Trials Early—for Good or Bad Case Studies: Interim Analyses That Stopped Trials Early—for Good or Bad Interim analyses play a crucial role in the management and evaluation of clinical trials. By analyzing data at predetermined intervals, researchers can make informed decisions about the continuation or termination of a trial….

Read More “Case Studies: Interim Analyses That Stopped Trials Early—for Good or Bad” »

Regulatory Expectations for Interim Analyses in Pivotal Programs Regulatory Expectations for Interim Analyses in Pivotal Programs Conducting clinical trials is a complex process governed by multiple regulatory frameworks, especially when it comes to pivotal programs. Among the many components of clinical trial design, interim analyses stand out as critical milestones. This article aims to provide…

Read More “Regulatory Expectations for Interim Analyses in Pivotal Programs” »

Documenting Interim Analysis Plans in Protocol, SAP and Charter In the dynamically evolving landscape of clinical research, the necessity of interim analyses has become increasingly acknowledged by regulatory bodies and sponsors alike. Conducting interim analyses allows for the monitoring of data throughout the lifecycle of a clinical trial, potentially informing decisions regarding safety, efficacy, and…

Read More “Documenting Interim Analysis Plans in Protocol, SAP and Charter” »

Adaptive Enrichment and Sample Size Re-Estimation at Interim Adaptive Enrichment and Sample Size Re-Estimation at Interim The ever-evolving landscape of clinical trials necessitates a robust and flexible approach to data analysis. This is particularly true in the context of interim analyses, where decisions must be made based on incomplete data. This step-by-step guide focuses on…

Read More “Adaptive Enrichment and Sample Size Re-Estimation at Interim” »

Group-Sequential Designs: Statistical Concepts and Practical Execution Group-Sequential Designs: Statistical Concepts and Practical Execution In the landscape of clinical trials, the need for efficiency and ethical considerations is paramount. Group-sequential designs provide robust statistical methodologies that allow researchers to conduct interim analyses, ensuring that clinical trials can be adapted based on accumulating data. This article…

Read More “Group-Sequential Designs: Statistical Concepts and Practical Execution” »

Maintaining Trial Integrity and Confidentiality During Interim Looks Maintaining Trial Integrity and Confidentiality During Interim Looks Interim analyses play a critical role in the management and oversight of clinical trials. Ensuring the integrity and confidentiality of these analyses is imperative for the credibility of clinical research outcomes. With the increasing complexity of clinical trials, especially…

Read More “Maintaining Trial Integrity and Confidentiality During Interim Looks” »